NanoLogix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NanoLogix and buy or sell other stocks, ETFs, and their options commission-free!

About NNLX

NanoLogix, Inc. is a biotechnology company, which engages in the research, development, commercialization, and production of filled Petri plates and rapid diagnostic test kits that detect viable bacteria and other microorganisms. The firm's products include BioNanoPore and FlatPack Petri Plates. 

CEO
Bret T. Barnhizer
CEOBret T. Barnhizer
Employees
Employees
Headquarters
Hubbard, Ohio
HeadquartersHubbard, Ohio
Founded
1989
Founded1989
Employees
Employees

NNLX Key Statistics

Market cap
11.96K
Market cap11.96K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.87K
Average volume1.87K
High today
$0.0001
High today$0.0001
Low today
$0.0001
Low today$0.0001
Open price
$0.0001
Open price$0.0001
Volume
11.97K
Volume11.97K
52 Week high
$0.0401
52 Week high$0.0401
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current NanoLogix(NNLX) stock price is $0.00, with a market capitalization of 11.96K.

During the trading session on 2026-06-10, NanoLogix(NNLX) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 11.97K, compared to an average daily volume of 1.87K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.04.

The stock's 52-week range extends from a low of $0.00 to a high of $0.04.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.